Skip to main content

All BHMG Oncology

Submissions from 2020 2020

Clinical experience of ONC201 in patients with recurrent H3 K27M-mutant spinal cord glioma, Yazmin Odia and Minesh Mehta

Early imaging marker of progressing glioblastoma: a window of opportunity, Yazmin Odia and Minesh Mehta

Single-agent ONC201 in recurrent H3 K27M-mutant diffuse midline glioma, Yazmin Odia and Minesh Mehta

Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study, Claudia Paba Prada

Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma, Guilherme Rabinowits

CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma, Guilherme Rabinowits

Cemiplimab Improves Health-Related Quality of Life (HRQoL) and Reduces Pain in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Results from a Post Hoc Exploratory Analysis of a Phase 2 Clinical Trial, Guilherme Rabinowits

Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck, Guilherme Rabinowits

Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma, Guilherme Rabinowits

RADT-31. PATTERNS OF CARE IN THE USE OF ADJUVANT RADIOTHERAPY AND CHEMOTHERAPY IN LOW GRADE GLIOMA PATIENTS IN THE UNITED STATES FROM 2010-2016, Warren Rehrer, Yazmin Odia, Muni Rubens, Noah Kalman, Michael Chuong, Rupesh Kotecha, Minesh Mehta, and Matthew Hall

The Use of Adjuvant Radiotherapy and Chemotherapy in Low Grade Glioma Patients in the United States from 2010-2016, Warren Rehrer, Muni Rubens, Katherine Von Werne, Yazmin Odia, Michael Chuong, Rupesh Kotecha, Minesh Mehta, and Matthew Hall

Principles of Radiation Therapy in Breast Cancer, Maria-Amelia Rodrigues

Recent Health Care Expenditure Trends Among Adult Cancer Survivors in United States, 2009-2016, Muni Rubens, Anshul Saxena, Sankalp Das, Chintan Bhatt, Emir Veledar, Peter McGranaghan, Ana Viamonte Ros, Yuliya Linhares, Yazmin Odia, Michael Chuong, Rupesh Kotecha, and Minesh Mehta

Bioengineered Exosomal Extracellular Vesicles in Cancer Therapeutics, Marco Ruiz Andia

Revisiting Early Palliative Care for Patients With Hematologic Malignancies and Bone Marrow Transplant: Why the Delay?, Marco Ruiz Andia

Survival Impact Of Postoperative Radiotherapy Timing In Pediatric And Young Adult Ependymoma, Sunny Shah, Kevin Gates, Chase Mallory, Muni Rubens, Haley Appel, Noah Kalman, Rupesh Kotecha, Minesh Mehta, and Matthew Hall

Dietary patterns and thyroid cancer risk: a population-based case-control study, Robert Udelsman

Genetic susceptibility may modify the association between cell phone use and thyroid cancer: A population-based case-control study in Connecticut, Robert Udelsman

Phytoestrogens and Thyroid Cancer Risk: A Population-Based Case-Control Study in Connecticut, Robert Udelsman

Polybrominated Diphenyl Ethers, Polybrominated Biphenyls, and Risk of Papillary Thyroid Cancer: A Nested Case-Control Study, Robert Udelsman

A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers, Miguel Villalona Calero

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology, Miguel Villalona Calero

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study, Miguel Villalona Calero

Safety of Proton Therapy for Patients With Primary Central Nervous System Germinoma and Non-Germinomatous Germ Cell Tumors: Report from a Multi-Institutional Database Analysis, Katherine Von Werne, Melanie Naranjo, Haley Appel, Warren Rehrer, Muni Rubens, Michael Chuong, Minesh Mehta, Rupesh Kotecha, and Matthew Hall

A Unique Airway Management Method for a Patient with a supraglottic Liposarcoma: A Case Report, Geoffrey Young

Submissions from 2019 2019

Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons, Horacio Asbun

Hepatic Angiosarcoma: A Multi-institutional, International Experience with 44 Cases, Horacio Asbun

Mentor of the Month Series: Laparoscopic Training in the United States, Horacio Asbun

Minimally Invasive Approaches to Pancreatic Cancer, Horacio Asbun

National Pancreatic Fistula Rates After Minimally Invasive Pancreaticoduodenectomy Are Improving with Time: A NSQIP Analysis, Horacio Asbun

Metastatic vertebral lesion mimicking an atypical hemangioma with negative 18F-FDG positron emission tomography-computed tomography, Ana Cecilia Belzarena Genovese

Prediction of Anal Cancer Recurrence After Chemoradiotherapy Using Quantitative Image Features Extracted From Serial (18)F-FDG PET/CT, Michael Chuong

Consensus Report From the Miami Liver Proton Therapy Conference, Michael Chuong and Alonso Gutierrez

Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA), Michael Chuong and Minesh Mehta

Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?, Michael Chuong and Minesh Mehta

Transoral Endoscopic Thyroidectomy Vestibular Approach, Neeta Erinjeri and Robert Udelsman

Volume-outcome relationship in parathyroid surgery, Neeta Erinjeri and Robert Udelsman

EBV-positive primary CNS lymphoma restricted to the conus medullaris in an immunocompetent host, Matthew Hall, Lyle Feinstein, Sergio Gonzalez-Arias, and Yazmin Odia

First clinical experience with DRD2/3 antagonist ONC201 in H3 K27M-mutant pediatric diffuse intrinsic pontine glioma: a case report, Matthew Hall, Yazmin Odia, Doured Daghistani, and Minesh Mehta

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201, Matthew Hall, Yazmin Odia, and Minesh Mehta

CMET-06. AN ANALYSIS OF RESPONSE ENDPOINTS FOR BRAIN METASTASIS PATIENTS TREATED WITH STEREOTACTIC RADIOSURGERY AND PD(L)-1 INHIBITORS, Rupesh Kotecha

Stereotactic radiosurgery with concurrent HER2-directed therapy is associated with improved objective response for breast cancer brain metastasis, Rupesh Kotecha

Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases, Rupesh Kotecha

Ten-year outcomes of moderately hypofractionated (70 Gy in 28 fractions) intensity modulated radiotherapy for localized prostate cancer, Rupesh Kotecha

The Impact of Sequencing PD-1/PD-L1 Inhibitors and Stereotactic Radiosurgery for Patients with Brain Metastasis, Rupesh Kotecha

The Complexity of Managing Large Brain Metastasis, Rupesh Kotecha and Minesh Mehta

Updates in the management of intradural spinal cord tumors: a radiation oncology focus, Rupesh Kotecha and Minesh Mehta

Barriers to Accrual and Enrollment in Brain Tumor Trials, Minesh Mehta

Comparison of Epidemiology and Outcomes in Neuro-Oncology Between the East and the West: Challenges and Opportunities, Minesh Mehta

Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis, Minesh Mehta

Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma, Minesh Mehta

Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes, Minesh Mehta

Letter: When Less is More: Dexamethasone Dosing for Brain Tumors, Minesh Mehta

Low-Grade Glioma Radiotherapy Treatment and Trials, Minesh Mehta

Management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous, Minesh Mehta

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges, Minesh Mehta

NRG brain tumor specialists consensus guidelines for glioblastoma contouring, Minesh Mehta

Preoperative Vs Postoperative Radiosurgery For Resected Brain Metastases: A Review, Minesh Mehta

Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933, Minesh Mehta

The association between BMI and BSA–temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525, Minesh Mehta

Core curriculum guidelines for a required clinical neurology experience, Yazmin Odia

Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations, Yazmin Odia

Incidental MITF, p.E318K Pathogenic Variant in Three Independent Cases Undergoing Hereditary Cancer Risk Assessment, Jessica Ordonez, Jeffrey Boyd, and Arelis Martir-Negron

Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma, Guilherme Rabinowits

Everolimus in Anaplastic Thyroid Cancer: A Case Series, Guilherme Rabinowits

Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence, Guilherme Rabinowits

Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma, Guilherme Rabinowits

Needle track seeding in renal mass biopsies, Andrew Renshaw, Alex Powell, Jorge Caso, and Edwin Gould

Lack of Efficacy of the Neutropenic Diet in Decreasing Infections among Cancer Patients: A Systematic Review, Muni Rubens, Anshul Saxena, Peter McGranaghan, Emir Veledar, Ana Viamonte Ros, and Rupesh Kotecha

Cell phone use and risk of thyroid cancer: a population-based case-control study in Connecticut, Robert Udelsman

Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive Patients, Fernando Vargas Madueno

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer, Miguel Villalona Calero

Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice, Miguel Villalona Calero

Submissions from 2018 2018

Removal of duodenal adenomas: the importance of proper technical application and operator expertise, Horacio Asbun

The Hemodynamic Effects of Intracavernosal Phenylephrine for the Treatment of Ischemic Priapism, Jorge Caso

Combining immunotherapy with radiation therapy in thoracic oncology, Michael Chuong

Correlation of radiation dose and activity with clinical outcomes in metastatic colorectal cancer after selective internal radiation therapy using yttrium-90 resin microspheres, Michael Chuong

Mid/Distal Esophageal Cancer and Gastroesophageal Junction Cancer (Siewert Type I and II), Michael Chuong

Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial, Michael Chuong

The Case for Proton Beam Therapy, Michael Chuong

Improving the therapeutic index for nonoperable esophageal cancer patients with modern radiation technologies, Michael Chuong and Matthew Hall

Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer, Michael Chuong, Man Yam, and Minesh Mehta

Counterpoint: Should Radiation Therapy Be Routinely Used in the Adjuvant Treatment of Stage III Endometrial Cancer?, John Paul Diaz

Robotic resection of Stage III lung cancer: an international retrospective study, Mark Dylewski

The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study, Mark Dylewski

Proton beam therapy for gastrointestinal cancers: past, present, and future, Matthew Hall and Michael Chuong

Early Objective Response as a Prognosticator for Final Objective Response and Survival following SRS for Brain Metastases Treated with Concurrent Systemic Therapy, Rupesh Kotecha

Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma, Rupesh Kotecha

(OA13) Stereotactic Radiosurgery and Concurrent Targeted Therapy: Improving the Response Rate for Breast Cancer Brain Metastasis, Rupesh Kotecha

Proton therapy patterns of care among pediatric and adult patients with CNS tumors, Rupesh Kotecha

Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing, Rupesh Kotecha

Ten-Year Outcomes and Toxicity with Moderately Hypofractionated (70 Gy in 28 fractions) Intensity-Modulated Radiation Therapy for Localized Prostate Cancer, Rupesh Kotecha

Recent advances in managing brain metastasis, Rupesh Kotecha and Minesh Mehta

Molecular Characterization of Renal Cell Carcinoma: A Potential three microRNA Prognostic Signature, Murugesan Manoharan

Surgical Management of Organ-Confined Prostate Cancer with Review of Literature and Evolving Evidence, Murugesan Manoharan

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848, Arelis Martir-Negron

Benchmarking the American Society of Breast Surgeon Member Performance for More Than a Million Quality Measure-Patient Encounters, Starr Mautner

Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely® Campaign, Starr Mautner

Virtual Surgical Planning for Correction of Delayed Presentation Scaphocephaly Using a Modified Melbourne Technique, Miguel Medina

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913, Minesh Mehta